BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · USD
$1.35
-0.02 (-1.5%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first BGLC analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 3.3M | |
|---|---|---|
| Revenue (ttm) | 5.3M | |
| Net income (ttm) | -2.9M | |
| EPS (ttm) | -$1.44 | |
| Shares out | 2.4M | |
| Volume | 9,200 | |
| Beta | 2.20 |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 5.3M
- Net income (ttm)
- -2.9M
- EPS (ttm)
- -$1.44
- Market cap
- 3.3M
Fair-value bridge
- Current price
- $1.35
In the news
Latest news · BGLC
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 3.3M
- P/S
- 0.6x
- P/B
- 0.4x
Profitability
- Gross margin
- 14.0%
- Operating margin
- -57.9%
- ROE
- -36.6%
- ROA
- -20.8%
- ROIC
- -66.3%
Balance sheet
- Debt / equity
- 0.04
- Current ratio
- 6.52
- Quick ratio
- 5.27
Trading
- Beta
- 2.20
- Volume
- 9,200
- Dividend yield
- 0.0%